Pharmaceutical Giant Shares the Wealth
(Page 2 of 2)
March/April 1996
By Walter V. Reid, Issues in Science and Technology (http://www4.nas.edu/nas/nashome.nsf)
What sets INBio apart is that its primary mission is conservation; bioprospecting is merely one means to that end. With its high percentage of conserved wild land, highly educated citizenry, relatively small indigenous population, small size, and considerable scientific capability, Costa Rica offers a good climate for testing innovative ways to manage biodiversity. Although INBio is a product of Costa Rica's particular biological, political, and social environment, its pioneering work is relevant throughout the tropics; other countries can learn a great deal that will help them manage their own biodiversity.
RELATED CONTENT
Biodiversity Resources Organizations and Books March April 1996 Compiled by Rebecca Scheib Related ...
An extensive scientific review gives the world another reason to go organic...
Giant J. Lo Frenzy! January 15, 2003 Rory Evans The New York Observer What is it about Jenn...
Colombian Tribe Topples Mighty Oil Giant May 17, 2002 Julie Madsen Colombian Tribe Topple...
Costa Rica is benefiting from its relationship with INBio in two ways, in addition to conservation. First, this agreement results in substantial transfer of technology to Costa Rica. Costa Rican scientists are being trained to discover and extract drugs, and INBio is already beginning to assess some of the drugs for their usefulness against local diseases. Second, Costa Rica stands to receive substantially greater sums from any commercial discovery than has historically been the case.
Reprinted from Issues in Science and Technology, Winter 1993-94. (note: publication is inactive see: National Academy of the Sciences at http://www4.nas.edu/nas/nashome.nsf).
Page:
<< Previous 1 | 2 |